UBS Group’s Core Scientific, Inc. Warrant CORZW Stock Holding History

UBS Group’s Portfolio CORZW Stock Details CORZW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-28,666	Closed	-$573	–	11539
2022 Q4	$573	Buy	+28,666	New	+$3.05K	﹤0.01%	10130
2022 Q3	–	Sell	-6,076	Closed	-$2K	–	11505
2022 Q2	$2K	Sell	6,076 -4,256	-41%	-$5.26K	﹤0.01%	9744
2022 Q1	$19K	Buy	+10,332	New	+$24.2K	﹤0.01%	7553
2021 Q4	–	Sell	-58	Closed	–	–	11094
2021 Q3	$0	Buy	+58	New	+$111	﹤0.01%	10440

Other funds holding CORZW

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

UBS Group's CORZW Position: Q1 2023 in Review

UBS Group sold out of Core Scientific, Inc. Warrant (CORZW) in Q1 2023, closing a stake of 28,666 shares — an estimated $573 sold.

UBS Group first reported a position in CORZW in Q3 2021 and held it in 4 quarters. The position peaked at $19K in Q1 2022. 1 fund tracked by Wall St. Rank holds CORZW as of Q1 2023.

UBS Group reported no remaining Core Scientific, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
UBS Group sold 28,666 Core Scientific, Inc. Warrant shares in Q1 2023, an estimated $573.
UBS Group first reported a position in Core Scientific, Inc. Warrant in Q3 2021 and held it in 4 quarters.
UBS Group's Core Scientific, Inc. Warrant position peaked at $19K in Q1 2022.
1 fund tracked by Wall St. Rank held Core Scientific, Inc. Warrant as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.